ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiovascular Biologics and Regenerative Medicine

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1596538

Shifting Landscapes: Dynamic changes from pro-to antiinflammatory Leukocyte phenotype in myocardial Ischemia/Reperfusion Injury

Provisionally accepted
Pia  KröningPia Kröning1,2*Nancy  SchanzeNancy Schanze1,3Katharina  NaberKatharina Naber1,2Daniela  StallmannDaniela Stallmann1,2Maximilian  MaulerMaximilian Mauler1,2Daniel  DuerschmiedDaniel Duerschmied1,2,3,4,5Dirk  WestermannDirk Westermann1,2Nadine  GauchelNadine Gauchel1,2
  • 1Department of Cardiology and Angiology I, University Heart Center Freiburg, Bad Krozingen, Germany
  • 2Faculty of Medicine, University of Freiburg, Freiburg, Germany
  • 3I Medical Clinic for Cardiology, Angiology, Hemostaseology and Internal intensive care medicine, University Medical Centre Mannheim, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany
  • 4European Center for Angioscience, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Baden-Württemberg, Germany
  • 5Partner Site Heidelberg/Mannheim, German Centre for Cardiovascular Research (DZHK), Heidelberg, Baden-Württemberg, Germany

The final, formatted version of the article will be published soon.

Background: The temporal and spatial dynamics of platelet–leukocyte complex (PLC) formation in myocardial ischemia reperfusion injury (I/R injury) .are still ill defined. Aim: To investigated the kinetics and spatial differences of platelet-monocyte -complexes (PMC) and platelet-neutrophil -complexes (PNC) complex formation in relationship to with cardiac function parametersover the first 7 days in a mouse model of myocardial (I/R injury).Methods: A time-course study was conducted (up to seven days in order t) was used to evaluate immune cell response and cardiac function following myocardial I/R injury. Myocardial I/R injury was induced by ligation of the left anterior descending coronary artery (LAD) for 30 minutes followed by reperfusion. Using flow cytometry leukocyte and platelet markers were evaluated in the heart, blood, spleen, and bone marrow. Echocardiography was performed in order to measure ejection fraction and fractional shortening which are accepted as indicators of cardiac function.Results: Expression of CD206-Geometric Mean Fluorescence Intensity (GMFI) indicative ofting an anti-inflammatory phenotype in neutrophils (N2) increased in PNCs at day 7. A statitstically significant decrease in the percentage Percentage of anti-inflammatory Ly6Clow PMCs (M2 PMCs) was significantly lower when compared to baseline observed as early as day 3, when compared to the baseline value. Flow cytometry analysis showed no significant variationsdifference in PNCs or PMCs within the area at risk (AAR) at indicated time points across the specified time points.. Increase A rise in neutrophils and monocytes is observed in the AAR, reaching its peak peaks on day 3.Conclusion: Our resultsThe present study demonstrates show that both anti-inflammatory Ly6Clow monocytes (M2) and N2 neutrophils participate in PLC formation following myocardial infarction (MI) and reperfusion. Our results suggest that the N2 phenotype prerequisite for PLC formation in AAR at day 7. These findings offer suggest that targeted interventions may be developed promising avenues for the development of targeted interventions to improve outcomes after myocardial I/R injury.

Keywords: ischemia reperfusion injury1, Myocardial infarction2, Neutrophils3, Monocytes4, platelet-leukocyte-complexes5, inflammation6

Received: 19 Mar 2025; Accepted: 09 Jun 2025.

Copyright: © 2025 Kröning, Schanze, Naber, Stallmann, Mauler, Duerschmied, Westermann and Gauchel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Pia Kröning, Department of Cardiology and Angiology I, University Heart Center Freiburg, Bad Krozingen, 79189, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.